Literature DB >> 32967961

Primary Swine Respiratory Epithelial Cell Lines for the Efficient Isolation and Propagation of Influenza A Viruses.

Victoria Meliopoulos1, Sean Cherry2, Nicholas Wohlgemuth2, Rebekah Honce2,3, Karen Barnard4, Phillip Gauger5, Todd Davis6, Peter Shult7, Colin Parrish4, Stacey Schultz-Cherry2.   

Abstract

Influenza virus isolation from clinical samples is critical for the identification and characterization of circulating and emerging viruses. Yet efficient isolation can be difficult. In these studies, we isolated primary swine nasal and tracheal respiratory epithelial cells and immortalized swine nasal epithelial cells (siNEC) and tracheal epithelial cells (siTEC) that retained the abilities to form tight junctions and cilia and to differentiate at the air-liquid interface like primary cells. Critically, both human and swine influenza viruses replicated in the immortalized cells, which generally yielded higher-titer viral isolates from human and swine nasal swabs, supported the replication of isolates that failed to grow in Madin-Darby canine kidney (MDCK) cells, and resulted in fewer dominating mutations during viral passaging than MDCK cells.IMPORTANCE Robust in vitro culture systems for influenza virus are critically needed. MDCK cells, the most widely used cell line for influenza isolation and propagation, do not adequately model the respiratory tract. Therefore, many clinical isolates, both animal and human, are unable to be isolated and characterized, limiting our understanding of currently circulating influenza viruses. We have developed immortalized swine respiratory epithelial cells that retain the ability to differentiate and can support influenza replication and isolation. These cell lines can be used as additional tools to enhance influenza research and vaccine development.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  influenza; respiratory cells; swine

Mesh:

Year:  2020        PMID: 32967961      PMCID: PMC7925196          DOI: 10.1128/JVI.01091-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Foot-and-mouth disease virus replicates only transiently in well-differentiated porcine nasal epithelial cells.

Authors:  Pradyot Dash; Paul V Barnett; Michael S Denyer; Terry Jackson; Catrina M A Stirling; Philippa C Hawes; Jennifer L Simpson; Paul Monaghan; Haru-H Takamatsu
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

2.  Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.

Authors:  E A Govorkova; S Kodihalli; I V Alymova; B Fanget; R G Webster
Journal:  Dev Biol Stand       Date:  1999

3.  Characterization of a porcine lung epithelial cell line suitable for influenza virus studies.

Authors:  S H Seo; O Goloubeva; R Webby; R G Webster
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors.

Authors:  Mikhail Matrosovich; Tatyana Matrosovich; Jackie Carr; Noel A Roberts; Hans-Dieter Klenk
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.

Authors:  Ding Yuan Oh; Ian G Barr; Jenny A Mosse; Karen L Laurie
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

6.  Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy.

Authors:  Crystal W Burke; John N Mason; Sherri L Surman; Bart G Jones; Emilie Dalloneau; Julia L Hurwitz; Charles J Russell
Journal:  PLoS Pathog       Date:  2011-07-07       Impact factor: 6.823

7.  Influenza pH1N1 Virus Accumulated H275Y Mutation in Neuraminidase during Propagation in MDCK Cells.

Authors:  Polina Mishel; Dmitrii Bychkov; Hannimari Kallio-Kokko; Miia Valkonen; Anu Kantele; Pirkko Mattila; Henrikki Almusa; Petri Jalovaara; Denis Kainov
Journal:  Genome Announc       Date:  2014-12-24

Review 8.  Immune History and Influenza Vaccine Effectiveness.

Authors:  Joseph A Lewnard; Sarah Cobey
Journal:  Vaccines (Basel)       Date:  2018-05-21

9.  Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation.

Authors:  Renee W Y Chan; Kit M Yuen; Wendy C L Yu; Carol C C Ho; John M Nicholls; J S Malik Peiris; Michael C W Chan
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

10.  Locally Acquired Human Infection with Swine-Origin Influenza A(H3N2) Variant Virus, Australia, 2018.

Authors:  Yi-Mo Deng; Frank Y K Wong; Natalie Spirason; Matthew Kaye; Rebecca Beazley; Migue L L Grau; Songhua Shan; Vittoria Stevens; Kanta Subbarao; Sheena Sullivan; Ian G Barr; Vijaykrishna Dhanasekaran
Journal:  Emerg Infect Dis       Date:  2020-01-17       Impact factor: 6.883

View more
  3 in total

1.  Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets.

Authors:  Lara S U Schwab; Sarah L Londrigan; Andrew G Brooks; Aeron C Hurt; Anshupa Sahu; Yi-Mo Deng; Jean Moselen; Christoph Coch; Thomas Zillinger; Gunther Hartmann; Patrick C Reading
Journal:  J Virol       Date:  2022-08-02       Impact factor: 6.549

2.  Innate Antiviral Cytokine Response to Swine Influenza Virus by Swine Respiratory Epithelial Cells.

Authors:  Abhijeet A Bakre; Les P Jones; Jackelyn Murray; Z Beau Reneer; Victoria A Meliopoulos; Sean Cherry; Stacey Schultz-Cherry; Ralph A Tripp
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

3.  Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines.

Authors:  Heidi Peck; Karen L Laurie; Steve Rockman; Vivian Leung; Hilda Lau; Sally Soppe; Cleve Rynehart; Chantal Baas; Heidi Trusheim; Ian G Barr
Journal:  NPJ Vaccines       Date:  2021-12-09       Impact factor: 7.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.